Massachusetts General Hospital is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Location | Boston, MA, USA |
|---|---|
| Type | Research Hospital / Academic Medical Center |
| Founded | 1811 |
| Affiliation | Harvard Medical School |
| Website | [massgeneral.org](https://www.massgeneral.org/) |
Massachusetts General Hospital (Mass General) is the original and largest teaching hospital of Harvard Medical School, founded in 1811. Located in Boston, Massachusetts, Mass General is consistently ranked among the top hospitals in the United States and is a world-renowned center for biomedical research.
The hospital houses the MassGeneral Institute for Neurodegenerative Disease (MIND), one of the leading centers for Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorder research in the world.
The MassGeneral Institute for Neurodegenerative Disease brings together researchers and clinicians working on:
| Disease Area | Research Focus |
|---|---|
| Alzheimer's Disease | Amyloid hypothesis, tau therapeutics, biomarkers, clinical trials |
| Parkinson's Disease | Alpha-synuclein, LRRK2, GBA, deep brain stimulation |
| ALS | SOD1, TDP-43, C9orf72, therapeutic screening |
| Frontotemporal Dementia | GRN, MAPT, TDP-43 pathology |
| Huntington's Disease | Genetic testing, symptomatic treatments |
Mass General collaborates with:
The study of Massachusetts General Hospital has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Hyman BT, et al. (2012). "National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease." Alzheimer's & Dementia. PMID:22213787.
Spillantini MG, et al. (1997). "Alpha-synuclein in Lewy bodies." Nature. PMID:9213294.
Neff RA, et al. (2021). "Molecular signatures of neuroinflammation in Alzheimer's disease." Nature Neuroscience. PMID:34594043.
MGH houses the MassGeneral Institute for Neurodegenerative Disease (MIND), the Alzheimer's Disease Research Center, the McCance Center for Brain Health, and the Center for Neurodegeneration and Repair. As a Harvard-affiliated hospital, MGH has extensive clinical research infrastructure.
MGH offers fellowship training programs in behavioral neurology, movement disorders, and neurocritical care. The hospital trains over 100 residents and fellows annually in partnership with Harvard Medical School.